Long-term maintenance of dystrophin expression and resistance to injury of skeletal muscle in gene edited DMD mice
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Long-term maintenance of dystrophin expression and resistance to injury of skeletal muscle in gene edited DMD mice
Authors
Keywords
MT: RNA/DNA Editing, CRISPR/Cas9, gene editing, exon reframing, Duchenne muscular dystrophy, AAV
Journal
Molecular Therapy-Nucleic Acids
Volume 28, Issue -, Pages 154-167
Publisher
Elsevier BV
Online
2022-03-08
DOI
10.1016/j.omtn.2022.03.004
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The nuclear envelope protein Net39 is essential for muscle nuclear integrity and chromatin organization
- (2021) Andres Ramirez-Martinez et al. Nature Communications
- CRISPR technologies for the treatment of Duchenne muscular dystrophy
- (2021) Eunyoung Choi et al. MOLECULAR THERAPY
- Precise correction of Duchenne muscular dystrophy exon deletion mutations by base and prime editing
- (2021) F. Chemello et al. Science Advances
- Enhanced CRISPR-Cas9 correction of Duchenne muscular dystrophy in mice by a self-complementary AAV delivery system
- (2020) Yu Zhang et al. Science Advances
- Correction of muscular dystrophies by CRISPR gene editing
- (2020) Francesco Chemello et al. JOURNAL OF CLINICAL INVESTIGATION
- Correction of three prominent mutations in mouse and human models of Duchenne muscular dystrophy by single-cut genome editing
- (2020) Yi-Li Min et al. MOLECULAR THERAPY
- p38 MAPK in Glucose Metabolism of Skeletal Muscle: Beneficial or Harmful?
- (2020) Eyal Bengal et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- In Vivo Gene Editing of Muscle Stem Cells with Adeno-Associated Viral Vectors in a Mouse Model of Duchenne Muscular Dystrophy
- (2020) Jennifer B. Kwon et al. Molecular Therapy-Methods & Clinical Development
- CRISPR-Cas9 corrects Duchenne muscular dystrophy exon 44 deletion mutations in mice and human cells
- (2019) Yi-Li Min et al. Science Advances
- Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy
- (2019) Christopher E. Nelson et al. NATURE MEDICINE
- Development of Novel Micro-dystrophins with Enhanced Functionality
- (2019) Julian N. Ramos et al. MOLECULAR THERAPY
- In Situ Modification of Tissue Stem and Progenitor Cell Genomes
- (2019) Jill M. Goldstein et al. Cell Reports
- AAV9 Edits Muscle Stem Cells in Normal and Dystrophic Adult Mice
- (2019) Michael E. Nance et al. MOLECULAR THERAPY
- Search-and-replace genome editing without double-strand breaks or donor DNA
- (2019) Andrew V. Anzalone et al. NATURE
- Barium chloride injures myofibers through calcium-induced proteolysis with fragmentation of motor nerves and microvessels
- (2019) Aaron B. Morton et al. Skeletal Muscle
- Correction of diverse muscular dystrophy mutations in human engineered heart muscle by single-site genome editing
- (2018) Chengzu Long et al. Science Advances
- Gene editing restores dystrophin expression in a canine model of Duchenne muscular dystrophy
- (2018) Leonela Amoasii et al. SCIENCE
- Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy
- (2017) Jerry R. Mendell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Single-cut genome editing restores dystrophin expression in a new mouse model of muscular dystrophy
- (2017) Leonela Amoasii et al. Science Translational Medicine
- CRISPR-mediated Genome Editing Restores Dystrophin Expression and Function in mdx Mice
- (2016) Li Xu et al. MOLECULAR THERAPY
- Absence of Dystrophin Disrupts Skeletal Muscle Signaling: Roles of Ca2+, Reactive Oxygen Species, and Nitric Oxide in the Development of Muscular Dystrophy
- (2016) David G. Allen et al. PHYSIOLOGICAL REVIEWS
- How much dystrophin is enough: the physiological consequences of different levels of dystrophin in themdxmouse
- (2015) Caroline Godfrey et al. HUMAN MOLECULAR GENETICS
- The TREAT-NMD DMD Global Database: Analysis of More than 7,000 Duchenne Muscular Dystrophy Mutations
- (2015) Catherine L. Bladen et al. HUMAN MUTATION
- Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy
- (2015) C. Long et al. SCIENCE
- In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy
- (2015) C. E. Nelson et al. SCIENCE
- Immune-mediated pathology in Duchenne muscular dystrophy
- (2015) Amy S. Rosenberg et al. Science Translational Medicine
- Gene expression in mdx mouse muscle in relation to age and exercise: aberrant mechanical–metabolic coupling and implications for pre-clinical studies in Duchenne muscular dystrophy
- (2014) Giulia Maria Camerino et al. HUMAN MOLECULAR GENETICS
- Screening of Duchenne Muscular Dystrophy (DMD) Mutations and Investigating Its Mutational Mechanism in Chinese Patients
- (2014) Chen Chen et al. PLoS One
- Therapy for Duchenne muscular dystrophy: renewed optimism from genetic approaches
- (2013) Rebecca J. Fairclough et al. NATURE REVIEWS GENETICS
- Humoral Immune Response to AAV
- (2013) Roberto Calcedo et al. Frontiers in Immunology
- The Effects of Low Levels of Dystrophin on Mouse Muscle Function and Pathology
- (2012) Maaike van Putten et al. PLoS One
- Genotype-phenotype analysis in 2,405 patients with a dystrophinopathy using the UMD-DMD database: a model of nationwide knowledgebase
- (2009) Sylvie Tuffery-Giraud et al. HUMAN MUTATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search